Egyptian pharmaceutical contract research organisation in Cairo, founded in 2014 by Dr Mosaad Morsi to provide clinical and bioanalytical services under good clinical practice and good laboratory practice principles following EMA, FDA, ICH and WHO guidance. Runs bioequivalence and bioavailability studies, having conducted more than two hundred and fifty in support of generic registration, together with comparative dissolution and biowaiver work, bioanalytical method development and validation, pharmacokinetic and statistical analysis and phase one clinical trials; it is approved by the Egyptian Ministry of Health from 2015 and by the Gulf Cooperation Council from 2017 and is certified to ISO 9001 and accredited to ISO/IEC 17025.
コメントはありません。
評価とコメントを残す